225 related articles for article (PubMed ID: 36054458)
1. Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits.
Kim BS; Inan S; Ständer S; Sciascia T; Szepietowski JC; Yosipovitch G
Exp Dermatol; 2022 Dec; 31(12):1900-1907. PubMed ID: 36054458
[TBL] [Abstract][Full Text] [Related]
2. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
[TBL] [Abstract][Full Text] [Related]
4. Intravenous difelikefalin for the treatment of hemodialysis pruritus.
Mahmoud RH; Mahmoud O; Yosipovitch G
Expert Rev Clin Immunol; 2024; 20(1):31-37. PubMed ID: 37847514
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications.
Elmariah S; Chisolm S; Sciascia T; Kwatra SG
JAAD Int; 2022 Jun; 7():156-163. PubMed ID: 35497636
[TBL] [Abstract][Full Text] [Related]
6. The Delta-Opioid Receptor Bidirectionally Modulates Itch.
Smith KM; Nguyen E; Ross SE
J Pain; 2023 Feb; 24(2):264-272. PubMed ID: 36464136
[TBL] [Abstract][Full Text] [Related]
7. Non-analgesic effects of opioids: peripheral opioid receptors as promising targets for future anti-pruritic therapies.
Reich A; Szepietowski JC
Curr Pharm Des; 2012; 18(37):6021-4. PubMed ID: 22747545
[TBL] [Abstract][Full Text] [Related]
8. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
9. Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development.
Cevikbas F; Steinhoff M; Ikoma A
CNS Neurosci Ther; 2011 Dec; 17(6):742-9. PubMed ID: 20950328
[TBL] [Abstract][Full Text] [Related]
10. Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia.
Chakrabarti S; Liu NJ; Gintzler AR
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20115-9. PubMed ID: 21041644
[TBL] [Abstract][Full Text] [Related]
11. ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models.
Jain MR; Patel RB; Prajapati KD; Vyas P; Bandyopadhyay D; Prajapati V; Bahekar R; Patel PN; Kawade HM; Kokare DM; Pawar V; Desai R
Eur J Pharmacol; 2022 Jun; 924():174961. PubMed ID: 35443192
[TBL] [Abstract][Full Text] [Related]
12. Antipruritic Effects of Kappa Opioid Receptor Agonists: Evidence from Rodents to Humans.
Inan S; Cowan A
Handb Exp Pharmacol; 2022; 271():275-292. PubMed ID: 33296031
[TBL] [Abstract][Full Text] [Related]
13. Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.
Bigliardi-Qi M; Gaveriaux-Ruff C; Pfaltz K; Bady P; Baumann T; Rufli T; Kieffer BL; Bigliardi PL
J Invest Dermatol; 2007 Jun; 127(6):1479-88. PubMed ID: 17185983
[TBL] [Abstract][Full Text] [Related]
14. Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis.
Inan S; Torres-Huerta A; Jensen LE; Dun NJ; Cowan A
Eur J Pharmacol; 2019 Dec; 864():172702. PubMed ID: 31568781
[TBL] [Abstract][Full Text] [Related]
15. Possible roles of epidermal opioid systems in pruritus of atopic dermatitis.
Tominaga M; Ogawa H; Takamori K
J Invest Dermatol; 2007 Sep; 127(9):2228-35. PubMed ID: 17611580
[TBL] [Abstract][Full Text] [Related]
16. Neuraxial opioid-induced itch and its pharmacological antagonism.
Ko MC
Handb Exp Pharmacol; 2015; 226():315-35. PubMed ID: 25861787
[TBL] [Abstract][Full Text] [Related]
17. Effects of butorphanol on morphine-induced itch and analgesia in primates.
Lee H; Naughton NN; Woods JH; Ko MC
Anesthesiology; 2007 Sep; 107(3):478-85. PubMed ID: 17721251
[TBL] [Abstract][Full Text] [Related]
18. Topical κ-opioid receptor agonist asimadoline improves dermatitis in a canine model of atopic dermatitis.
Marsella R; Ahrens K; Wilkes R; Soeberdt M; Abels C
Exp Dermatol; 2022 Apr; 31(4):628-632. PubMed ID: 34839557
[TBL] [Abstract][Full Text] [Related]
19. Opioid Receptors in Psoriatic Skin: Relationship with Itch.
Kupczyk P; Reich A; Hołysz M; Gajda M; Wysokińska E; Kobuszewska A; Nevozhay D; Nowakowska B; Strzadała L; Jagodziński PP; Szepietowski JC
Acta Derm Venereol; 2017 May; 97(5):564-570. PubMed ID: 27958613
[TBL] [Abstract][Full Text] [Related]
20. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
